In a report published Wednesday, Oppenheimer analysts initiated coverage on Tesla Motors, Inc. (TSLA) with a ‘Outperform’ rating and $340 price target.
On valuation measures, Tesla Motors Inc. shares currently have a PEG and forward P/E ratio of (1.97) and 104.44, respectively. Price/sales for the same period is 8.52 while EPS is ($4.14). Currently there are 7 analysts that rate TSLA a ‘Buy’, 6 rate it a ‘Hold’. 2 analysts rate it a ‘Sell’. TSLA has a median Wall Street price target of $290.00 with a high target of $465.00.
In the past 52 weeks, shares of Palo Alto, California-based company have traded between a low of $181.40 and a high of $286.65 and are now at $252.46.
Shares are down 12.03% year-over-year ; up 11.58% year-to-date.
Investment analysts at Oppenheimer initiated coverage on shares of SolarCity Corporation (SCTY) in a note issued to investors on Wednesday. The firm set a ‘Outperform’ rating and a $66 price target on the stock suggesting a potential upside of 37% from the stock’s current price of $48.12.
SolarCity Corp., currently valued at $4.69 billion, has a median Wall Street price target of $75.00 with a high target of $105.00. Approximately 1.30 million shares have already changed hands, compared to the stock’s average daily volume of 3.79 million.
In the past 52 weeks, shares of San Mateo, California-based solar company have traded between a low of $34.65 and a high of $75.90 with the 50-day MA and 200-day MA located at $51.31 and $54.46 levels, respectively. Additionally, shares of SCTY have a Relative Strength Index (RSI) and MACD indicator of 47.55 and +2.38, respectively.
SolarCity Corp. currently prints a year-to-date loss of 6.32%.
Shares of SunPower Corporation (SPWR) are up 0.17, or 0.71%, at $24.26 in midday trading on Wednesday. Oppenheimer analysts today initiated coverage of the name, giving it an ‘Outperform’ rating and price target of $31.
On valuation measures, SPWR shares are currently priced at 21.74x this year’s forecasted earnings, compared to the industry’s $11.61x earnings multiple. Ticker has a forward P/E of 13.74 and t-12 price-to-sales ratio of 1.24. EPS for the same period is $1.12.
Over the past year, shares of San Jose, California-based company have traded between a low of $18.25 and a high of $38.66.
Shares are down 38.75% year-over-year and 6.74% year-to-date.
Raymond James is out with a report this morning initiating coverage of TG Therapeutics, Inc. (TGTX) with a ‘Strong Buy’ rating.
In the past 52 weeks, shares of TGTX have traded between a low of $9.03 and a high of $20.00 and are now trading at $11.52.
Shares are down 27.71% since the beginning of the year.
Sterne Agee CRT initiated shares of NXP Semiconductors NV (NXPI) with a ‘Buy’ rating. Right now, ticker is sitting at $90.18, a 0.55% loss, and is 18.69% higher year-to-date, compared with an 1.32% loss in the S&P 500.
NXPI closed Tuesday at $90.68. The company has a current market cap of 20.96 billion.
Investment analysts at Jefferies initiated coverage on shares of Gilead Sciences Inc. (GILD) in a note issued to investors on Wednesday. The firm set a ‘Hold’ rating on the stock.
Gilead Sciences Inc., currently valued at $155.05 billion, has a median Wall Street price target of $128.00 with a high target of $141.00.